Stocks GSHD Financial statements
Financial statementsGoosehead Insurance, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 9 fiscal years, taken from the XBRL data Goosehead Insurance, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2018 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 42.7 | 60.1 | 77.5 | 117 | 151 | 209 | 261 | 315 | 365 |
| General and administrative | 8.6 | 13.1 | 19 | 25 | 39.8 | 52.9 | 62.1 | 67.1 | 81.4 |
| Operating expenses | 35.1 | 74.1 | 63.4 | 97.1 | 143 | 199 | 228 | 253 | 291 |
| Operating income | 7.61 | -13.9 | 14.1 | 19.9 | 8.67 | 10.1 | 33 | 61.1 | 74.4 |
| Interest expense | 2.47 | 4.27 | 2.39 | 2.31 | 2.85 | 5 | 6.57 | 7.34 | 23.8 |
| Interest income | 0.42 | 0.62 | 0.81 | 1.15 | |||||
| Other non-operating income | 3.54 | -0.02 | 0 | 0.09 | 0.19 | 0 | 0 | -7.1 | 0.19 |
| Pre-tax income | 8.68 | -18.2 | 11.7 | 17.7 | 6 | 5.13 | 26.4 | 46.7 | 50.8 |
| Income tax | 0 | 0.45 | 1.3 | -1.04 | -2.29 | 2.5 | 2.69 | -2.41 | 6.4 |
| Net income to minority interests | 8.68 | -9.76 | 6.82 | 9.47 | 2.89 | 2.07 | 9.56 | 18.7 | 16.6 |
| Net income | 0 | -8.9 | 3.57 | 9.29 | 5.4 | 0.57 | 14.1 | 30.4 | 27.8 |
| EBITDA | 8.49 | -11.4 | 16.2 | 23.5 | 13.8 | 17.2 | 42.2 | 71.7 | 85.7 |
| EPS, basic | -0.66 | 0.24 | 0.55 | 0.28 | 0.03 | 0.59 | 1.23 | 1.11 | |
| EPS, diluted | -0.66 | 0.22 | 0.51 | 0.26 | 0.03 | 0.55 | 1.16 | 1.04 | |
| Shares, basic (weighted) | 13.6 | 14.9 | 16.8 | 19.2 | 21 | 23.9 | 24.7 | 25 | |
| Shares, diluted (weighted) | 13.6 | 16.1 | 18.4 | 20.8 | 21.8 | 38.4 | 38.3 | 38.1 |
Balance sheet
| FY2018 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 4.95 | 18.6 | 14.3 | 24.9 | 28.5 | 28.7 | 42 | 54.3 | 34.4 |
| Other current assets | 0 | 0 | 1.99 | 3.71 | 4.79 | 4.33 | 7.89 | 8.14 | 7.55 |
| Total current assets | 7.72 | 22.8 | 26.7 | 50.6 | 50.3 | 54.1 | 74.6 | 109 | 93.2 |
| Property, plant and equipment | 6.85 | 7.58 | 9.54 | 16.7 | 24.9 | 35.3 | 30.3 | 24.1 | 21.5 |
| Lease right-of-use assets | 22.5 | 32.7 | 44.1 | 38.4 | 37.4 | 34.1 | |||
| Intangible assets | 0.22 | 0.25 | 0.45 | 0.55 | 2.8 | 4.49 | 17.3 | 25.1 | 39.7 |
| Other non-current assets | 0.57 | 0.13 | 1.36 | 3.94 | 4.74 | 4.19 | 3.87 | 5.55 | 6.98 |
| Total assets | 16.7 | 34.8 | 64.6 | 186 | 270 | 321 | 355 | 398 | 415 |
| Accounts payable | 2.76 | 3.98 | 5.03 | 8.1 | 13 | 16 | 16.4 | 22.9 | 33.6 |
| Deferred revenue | 1.06 | 0.53 | 2.77 | 4.23 | 6.05 | 6.03 | 4.13 | 3.28 | 3.24 |
| Short-term debt | 0.5 | 2.5 | 4 | 3.5 | 4.38 | 6.88 | 9.38 | 10.1 | 2.99 |
| Total current liabilities | 5.77 | 7.81 | 13.4 | 20.4 | 30.3 | 37.1 | 40.9 | 46.5 | 58.3 |
| Long-term debt | 48.2 | 45.9 | 42.2 | 79.4 | 118 | 86.7 | 67.6 | 82.3 | 289 |
| Lease liabilities | 32.9 | 47.3 | 64.9 | 57.4 | 54.5 | 51.2 | |||
| Total liabilities | 57.8 | 60 | 95.6 | 224 | 339 | 355 | 338 | 359 | 578 |
| Total debt | 48.7 | 48.4 | 36.5 | 82.9 | 123 | 93.6 | 76.9 | 92.3 | 292 |
| Paid-in capital | 0 | 11.9 | 14.4 | 29.4 | 46.3 | 70.9 | 73.4 | 58.9 | 37.5 |
| Retained earnings | 0 | -20.8 | -23.8 | -34.6 | -60.7 | -60.6 | -45.8 | -15.4 | -133 |
| Shareholders' equity | -41.1 | -8.5 | -9.01 | -4.88 | -14 | 10.7 | 28 | 43.9 | -95.5 |
| Minority interests | 0 | -16.7 | -22 | -33.5 | -55.2 | -44.3 | -11.2 | -4.81 | -67.3 |
| Total equity | -41.1 | -25.2 | -31 | -38.4 | -69.2 | -33.6 | 16.8 | 39.1 | -163 |
| Total liabilities and equity | 16.7 | 34.8 | 64.6 | 186 | 270 | 321 | 355 | 398 | 415 |
Cash flow statement
| FY2018 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Net income | 8.68 | -18.7 | 10.4 | 18.8 | 8.3 | 2.63 | 23.7 | 49.1 | 44.5 |
| Depreciation and amortization | 0.88 | 2.52 | 2.15 | 3.57 | 5.12 | 7.11 | 9.24 | 10.5 | 11.3 |
| Stock-based compensation | 0 | 27 | 1.53 | 4.75 | 7.29 | 19.6 | 24 | 28 | 23.4 |
| Deferred income tax | 0 | -1.73 | -11.4 | -49.1 | -43.3 | -22.5 | -22.1 | -3.75 | 5.89 |
| Change in payables | 1.33 | 1.21 | 0.91 | 2.54 | 4 | 2.51 | -0.11 | 5.06 | 6.91 |
| Cash from operations | 13.5 | 10.3 | 21.2 | 24.6 | 35.4 | 36 | 50.8 | 71.5 | 91.8 |
| Capital expenditures | -6.22 | -2.1 | -3.69 | -9.98 | -12.7 | -10.1 | -4.45 | -0.98 | -5.67 |
| Cash from investing | -6.14 | -2.22 | -4.08 | -10.3 | -15.4 | -12.6 | -19.2 | -12.4 | -23.5 |
| Stock issued | 4.5 | 4.6 | 6.1 | 9.9 | 12.2 | 13.6 | |||
| Share buybacks | 0 | 0 | -63.2 | -81.7 | |||||
| Dividends paid | -25.5 | -80.1 | -18.7 | -44.7 | -60 | 0 | 0 | 0 | -146 |
| Cash from financing | -6.24 | 5.59 | -20.9 | -3.33 | -15.8 | -23.6 | -18 | -45.2 | -88.3 |
| Net change in cash | 1.17 | 13.6 | -3.75 | 11 | 4.24 | -0.09 | 13.7 | 13.9 | -20 |
| Free cash flow | 7.33 | 8.18 | 17.5 | 14.7 | 22.7 | 25.9 | 46.4 | 70.6 | 86.1 |
| Interest paid | 2 | 3.21 | 2.17 | 1.89 | 2.35 | 4.77 | 6.37 | 6.88 | 21.7 |
| Income taxes paid | 0 | 0.3 | 1.18 | 0.27 | 0.27 | 0.48 | 0.7 | 0.63 | 0.93 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Operating margin | 23.3% | Operating income / revenue. |
| EBITDA margin | 26.4% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 17.6% | Pre-tax income / revenue. |
| Net margin | 8.8% | Net income / revenue. |
| FCF margin | 19.8% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 21.4% | Cash from operations / revenue. |
| Effective tax rate | 17.1% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on assets (ROA) | 8.7% | Net income / average total assets. |
| Return on invested capital (ROIC) | 42.9% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| Stock-based pay / revenue | 5.5% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 1.6% | Capital expenditures / revenue. |
| D&A / revenue | 3.1% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 16.2% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 20.4% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 25.6% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 21.8% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 94.4% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | 30.1% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 19.6% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 70.7% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 29.5% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | -8.5% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 266.6% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | 24.5% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | -10.3% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | 226.1% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | 15.3% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 28.3% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 36.6% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 30.1% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 22.0% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 49.2% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | 42.5% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | -317.6% | Book value vs the same period a year earlier. Only from a positive base. |
| Total assets growth, 1y | 4.3% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 8.9% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 17.4% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -0.5% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 20.5% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 15.7% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.54x | Current assets / current liabilities. |
| Quick ratio | 0.43x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.43x | (Cash + short-term investments) / current liabilities. |
| Debt / assets | 78.0% | Total debt / total assets. |
| Liabilities / assets | 146.3% | Total liabilities / total assets. |
| Net debt | $293.7M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 2.77x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | 4.10x | Operating income / interest expense. |
| Working capital | $30.1M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 11.9% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -$160.8M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.99x | Revenue / average total assets. |
| Fixed asset turnover | 18.5x | Revenue / average property, plant and equipment. |
| FCF conversion | 225.8% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 7.5% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.99 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $11.26 | Revenue / diluted weighted shares. |
| FCF per share | $2.23 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $2.41 | Cash from operations / diluted weighted shares. |
| Book value per share | -$3.15 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | -$4.50 | Tangible book value / shares outstanding. |
| Cash per share | $0.66 | (Cash + short-term investments) / shares outstanding. |
| Buybacks / FCF | 169.4% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $1.61B | Share price x shares outstanding. |
| Enterprise value | $1.90B | Market cap + total debt - cash - short-term investments. |
| P/E | 45.5x | Market cap / net income. Only when net income is positive. |
| P/S | 3.99x | Market cap / revenue. |
| P/FCF | 20.2x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 18.6x | Market cap / cash from operations, when positive. |
| EV/Sales | 4.72x | Enterprise value / revenue. |
| EV/EBIT | 20.3x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 17.9x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 23.8x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 5.0% | Free cash flow / market cap. |
| Earnings yield | 2.2% | Net income / market cap (the inverse of P/E). |
| Shareholder yield | 8.4% | (Dividends paid + share buybacks) / market cap. |
| PEG | 0.20x | P/E / EPS growth per year over 3 years (in percent). Only when both are positive. |
What was Goosehead Insurance, Inc.'s revenue in fiscal 2025?
Goosehead Insurance, Inc. reported revenue of $365.3M for fiscal 2025, 16.2% higher than the year before.
Was Goosehead Insurance, Inc. profitable in fiscal 2025?
Yes. Net income was $27.8M, a net margin of 7.6%.
How much free cash flow did Goosehead Insurance, Inc. generate in fiscal 2025?
Cash from operations of $91.8M minus capital expenditures of $5.7M left free cash flow of $86.1M.